Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

464 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intermittent or Continuous Panitumumab Plus Fluorouracil, Leucovorin, and Irinotecan for First-Line Treatment of RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The IMPROVE Trial.
Avallone A, Giuliani F, De Stefano A, Santabarbara G, Nasti G, Montesarchio V, Rosati G, Cassata A, Leo S, Romano C, Tamburini E, Silvestro L, Lotesoriere C, Nappi A, Santini D, Petrillo A, Colombo A, Febbraro A, Leone A, Mannavola F, Laterza MM, Izzo F, Sobrero A, Delrio P, Giannarelli D, Budillon A. Avallone A, et al. Among authors: giuliani f. J Clin Oncol. 2024 Nov 22:JCO2400979. doi: 10.1200/JCO.24.00979. Online ahead of print. J Clin Oncol. 2024. PMID: 39576946
Real-World Safety and Effectiveness of Dimethyl Fumarate in Patients with MS: Results from the ESTEEM Phase 4 and PROCLAIM Phase 3 Studies with a Focus on Older Patients.
Mao-Draayer Y, Bar-Or A, Balashov K, Foley J, Smoot K, Longbrake EE, Robertson D, Mendoza JP, Lewin JB, Everage N, Božin I, Lyons J, Mokliatchouk O, Bame E, Giuliani F. Mao-Draayer Y, et al. Among authors: giuliani f. Adv Ther. 2024 Nov 21. doi: 10.1007/s12325-024-03047-w. Online ahead of print. Adv Ther. 2024. PMID: 39570545
Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy in patients with advanced HER2-negative gastric or gastro-oesophageal junction cancer (ARMANI): a randomised, open-label, multicentre, phase 3 trial.
Randon G, Lonardi S, Fassan M, Palermo F, Tamberi S, Giommoni E, Ceccon C, Di Donato S, Fornaro L, Brunetti O, De Vita F, Bittoni A, Chini C, Spallanzani A, Nappo F, Bethaz V, Strippoli A, Latiano T, Cardellino GG, Giuliani F, Morano F, Niger M, Raimondi A, Prisciandaro M, Pircher CC, Sciortino C, Marchesi S, Garattini SK, Airò G, Miceli R, Di Bartolomeo M, Pietrantonio F. Randon G, et al. Among authors: giuliani f. Lancet Oncol. 2024 Nov 15:S1470-2045(24)00580-1. doi: 10.1016/S1470-2045(24)00580-1. Online ahead of print. Lancet Oncol. 2024. PMID: 39557058
Monitoring equity in the delivery of health services: a Delphi process to select healthcare equity indicators.
Buclin CP, Doninelli M, Bertini L, Bodenmann P, Cullati S, Chiolero A, Degiorgi A, Gemperli A, Hugli O, Jachmann A, Jackson Y, Marti J, Morisod K, Obas KA, Rüter F, Safford J, Sanchis-Zozaya J, Schick M, Giuliani F, Courvoisier DS. Buclin CP, et al. Among authors: giuliani f. Swiss Med Wkly. 2024 Oct 3;154:3714. doi: 10.57187/s.3714. Swiss Med Wkly. 2024. PMID: 39463419 Free article.
Evaluating CDK4/6 Inhibitor Therapy in Elderly Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: A Retrospective Real-World Multicenter Study.
Fedele P, Landriscina M, Moraca L, Cusmai A, Gnoni A, Licchetta A, Guarini C, Lanotte L, Pappagallo MN, Melaccio A, Giordano G, Maselli FM, Pinto A, Giuliani F, Chiuri V, Giotta F, Gadaleta-Caldarola G. Fedele P, et al. Among authors: giuliani f. Cancers (Basel). 2024 Oct 10;16(20):3442. doi: 10.3390/cancers16203442. Cancers (Basel). 2024. PMID: 39456537 Free PMC article.
Observing the crack tip behavior at the nanoscale during fracture of ceramics.
Gavalda-Diaz O, Emmanuel M, Berenov A, Marquardt K, Saiz E, Giuliani F. Gavalda-Diaz O, et al. Among authors: giuliani f. Proc Natl Acad Sci U S A. 2024 Oct 22;121(43):e2408292121. doi: 10.1073/pnas.2408292121. Epub 2024 Oct 17. Proc Natl Acad Sci U S A. 2024. PMID: 39418311 Free PMC article.
How Time, Living Situation, and Stress Related to Technology Influence User Acceptance and Usability of a Socialization Service for Older Adults and Their Formal and Informal Caregivers: Six-Month Pilot Study.
Pani J, Lorusso L, Toccafondi L, D'Onofrio G, Ciccone F, Russo S, Giuliani F, Sancarlo D, Calamida N, Vignani G, Pihl T, Rovini E, Cavallo F, Fiorini L. Pani J, et al. Among authors: giuliani f. JMIR Aging. 2024 Oct 9;7:e54736. doi: 10.2196/54736. JMIR Aging. 2024. PMID: 39383481 Free PMC article.
Artificial intelligence: A new tool in the pathologist's armamentarium for the diagnosis of IBD.
Cannarozzi AL, Massimino L, Latiano A, Parigi TL, Giuliani F, Bossa F, Di Brina AL, Ungaro F, Biscaglia G, Danese S, Perri F, Palmieri O. Cannarozzi AL, et al. Among authors: giuliani f. Comput Struct Biotechnol J. 2024 Sep 11;23:3407-3417. doi: 10.1016/j.csbj.2024.09.003. eCollection 2024 Dec. Comput Struct Biotechnol J. 2024. PMID: 39345902 Free PMC article. Review.
464 results